Screener
Medpace Holdings, Inc. MEDP Production and delivery
Production and delivery at other companies
Segments
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DirectOperatingCosts.
The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001668397-26-000025
| (Amounts in thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Direct service costs, excluding depreciation and amortization | 202,555 | 185,826 | 400,829 | 363,642 |
| Reimbursed out-of-pocket expenses | 303,139 | 237,472 | 615,143 | 439,876 |
| Total direct costs | 505,694 | 423,298 | 1,015,972 | 803,518 |
| Selling, general and administrative | 48,103 | 46,664 | 96,020 | 104,561 |
| Depreciation | 6,555 | 6,777 | 13,306 | 13,471 |
| Amortization | 155 | 237 | 310 | 473 |
| Total operating expenses | 560,507 | 476,976 | 1,125,608 | 922,023 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Medpace Holdings, Inc.'s production and delivery?
- Medpace Holdings, Inc. (MEDP) reported production and delivery of $505.69M in Q2 2026.
- How has Medpace Holdings, Inc.'s production and delivery changed year-over-year?
- Medpace Holdings, Inc.'s production and delivery increased by 19.5% year-over-year, from $423.3M to $505.69M.
- What is the long-term trend for Medpace Holdings, Inc.'s production and delivery?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s production and delivery has grown at a 21.4% compound annual growth rate (CAGR), from $814.22M to $1.77B.
- What does production and delivery mean?
- Direct operating costs represent the expenses directly attributable to the delivery of clinical research services, including personnel costs for clinical staff and site-related expenses. This metric is critical for assessing the efficiency of service delivery and the direct cost structure required to support project volume.
Ask your AI about Medpace Holdings, Inc.'s production and delivery.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude